These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15846528)

  • 21. Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners.
    Florin TH
    Med J Aust; 2004 Mar; 180(6):310-2; author reply 311-2. PubMed ID: 15012575
    [No Abstract]   [Full Text] [Related]  

  • 22. Uptake of new drugs in rural and urban areas of Queensland, Australia: the example of COX-2 inhibitors.
    Behan K; Cutts C; Tett SE
    Eur J Clin Pharmacol; 2005 Mar; 61(1):55-8. PubMed ID: 15785961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemicrania continua responds to cyclooxygenase-2 inhibitors.
    Peres MF; Silberstein SD
    Headache; 2002 Jun; 42(6):530-1. PubMed ID: 12167145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Topical pharmacology. COX-2 inhibitors].
    Heinzl S
    Med Monatsschr Pharm; 1999 Oct; 22(10):298-304. PubMed ID: 10540801
    [No Abstract]   [Full Text] [Related]  

  • 25. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
    Hochberg MC
    Curr Top Med Chem; 2005; 5(5):443-8. PubMed ID: 15974939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COX-2 inhibitors and cardiovascular toxicity: a class effect?
    Laible B
    S D J Med; 2005 Mar; 58(3):93-4. PubMed ID: 15794479
    [No Abstract]   [Full Text] [Related]  

  • 27. COX-2 inhibitors--a lesson in unexpected problems.
    Drazen JM
    N Engl J Med; 2005 Mar; 352(11):1131-2. PubMed ID: 15713947
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood pressure in Native Americans switched from celecoxib to rofecoxib.
    Fredy J; Diggins DA; Morrill GB
    Ann Pharmacother; 2005 May; 39(5):797-802. PubMed ID: 15797981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translational medicine: targetting cyclo-oxygenase isozymes to prevent cancer.
    Sharma RA
    QJM; 2002 May; 95(5):267-73. PubMed ID: 11978897
    [No Abstract]   [Full Text] [Related]  

  • 30. Treating pain with COX-2 inhibitors.
    Rodgers E
    Nurse Pract; 1999 Nov; 24(11):95-6, 99-100, 102. PubMed ID: 10618817
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of cyclooxygenase-2 inhibitors on blood pressure.
    Johnson DL; Hisel TM; Phillips BB
    Ann Pharmacother; 2003 Mar; 37(3):442-6. PubMed ID: 12639178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2 inhibitors. Magic bullets or merely mortal?
    Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of cyclooxygenase-2-specific inhibitors.
    Cannon GW; Breedveld FC
    Am J Med; 2001 Feb; 110 Suppl 3A():6S-12S. PubMed ID: 11173044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol).
    Graham GG; Graham RI; Day RO
    Curr Pharm Des; 2002; 8(12):1063-75. PubMed ID: 11945151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COX-2 inhibitors in rheumatoid arthritis.
    Sundy JS
    Curr Rheumatol Rep; 2001 Feb; 3(1):86-91. PubMed ID: 11177775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective.
    Hochberg MC
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current status of COX II inhibitors in therapy of rheumatoid arthritis in comparison with conventional non-steroidal anti-inflammatory agents. Attempt at an evaluation with regard to evidence-based medicine].
    Krüger K
    Z Rheumatol; 2001 Dec; 60(6):481-4. PubMed ID: 11826746
    [No Abstract]   [Full Text] [Related]  

  • 38. Thromboembolic cardiovascular risk among arthritis patients using cyclooxygenase-2-selective inhibitor or nonselective cyclooxygenase inhibitor nonsteroidal anti-inflammatory drugs.
    Spalding WM; Reeves MJ; Whelton A
    Am J Ther; 2007; 14(1):3-12. PubMed ID: 17303969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
    Gibofsky A
    J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database.
    Zhao SZ; Reynolds MW; Lejkowith J; Whelton A; Arellano FM
    Clin Ther; 2001 Sep; 23(9):1478-91. PubMed ID: 11589261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.